Atara Biotherapeutics, Inc. (ATRA) vs Citius Oncology, Inc. (CTOR)
A side-by-side comparison of Atara Biotherapeutics, Inc. and Citius Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATRA
Atara Biotherapeutics, Inc.
$9.38HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
CTOR
Citius Oncology, Inc.
$0.88HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ATRA vs CTOR
growth of $100 · dividends reinvested · last 2yATRA -9.9% (-5.1%/yr)CTOR -92.4% (-72.4%/yr)ATRA compounded faster over this window
Log scale — wide-divergence pair
ATRA CTOR
ATRA vs CTOR: by the numbers
- •ATRA is the larger company ($85M vs $82M market cap).
- •Both run net losses; ATRA's is the smaller (-269.42% vs -648.32% net margin).
Metrics side by side
Valuation
| Metric | ATRA | CTOR |
|---|---|---|
| Forward P/E | N/A | 8.80 |
| P/S ratio | 13.64 | 11.52 |
| P/B ratio | N/A | 2.03 |
Profitability
| Metric | ATRA | CTOR |
|---|---|---|
| Gross margin | 82.44% | 0.00% |
| Operating margin | 29.69% | 0.00% |
| Net margin | -269.42% | -648.32% |
| ROE | N/A | -114.06% |
| ROIC | -100.35% | -88.72% |
Growth (annualized)
| Metric | ATRA | CTOR |
|---|---|---|
| Revenue CAGR (5Y) | 56.10% | N/A |
| Total return CAGR (5Y) | -53.60% | N/A |
Go deeper
Dig into the metrics
Atara Biotherapeutics ROECitius Oncology ROEAtara Biotherapeutics operating marginCitius Oncology operating marginAtara Biotherapeutics revenue growthCitius Oncology revenue growthAtara Biotherapeutics free cash flowCitius Oncology free cash flow
Atara Biotherapeutics & Citius Oncology appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.